This is a paid press release. Contact the press release distributor directly with any enquiries.
Reckitt Announces Expiration and Results of Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044
PR Newswire
Fri, 14 August 2026 at 3:00 pm GMT+5:30
5 min read
- US582839AG14
- RKT
+7.05%
SLOUGH, United Kingdom, Aug. 14, 2026 /PRNewswire/ — Reckitt Benckiser Group plc (“Reckitt”) (LSE: RKT) announced today (i) the expiration and results of its wholly-owned subsidiary, Mead Johnson Nutrition Company’s (“MJN”), previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding 4.600% Senior Notes due 2044 (CUSIP No. 582839 AG1; ISIN US582839AG14) (the “Notes”) and (ii) receipt of consents in connection with MJN’s previously announced solicitation of consents (the “Consents”) from registered holders (each, a “Holder” and, collectively, the “Holders”) of the Notes (the “Consent Solicitation”) to proposed amendments to the indenture governing the Notes, as supplemented (the “Indenture”), providing for, among other things, the elimination of substantially all of the restrictive covenants and certain events of default and the release of Reckitt’s guarantee of the Notes (the “Proposed Amendments”). The terms and conditions of the Tender Offer and the Consent Solicitation are described in the Offer to Purchase and Consent Solicitation Statement, dated August 5, 2026 (the “Statement”).
$400,415,000 aggregate principal amount of Notes were validly tendered and not validly withdrawn prior to 5:00 p.m., New York City time, on August 13, 2026 (the “Expiration Time”) pursuant to the Tender Offer and Consents delivered pursuant to the Consent Solicitation. The settlement date for Notes validly tendered and not validly withdrawn prior to the Expiration Time and accepted for purchase by MJN is expected to be August 18, 2026 (the “Settlement Date”). Holders of Notes that were validly tendered and not validly withdrawn prior to the Expiration Time will receive the total consideration of $898.00 per $1,000 principal amount of Notes tendered and accepted for purchase, plus accrued and unpaid interest from the last date on which interest had been paid to, but excluding, the Settlement Date. $99,585,000 in aggregate principal amount of Notes will be outstanding on the Settlement Date after giving effect to the settlement of such tendered Notes.
The Tender Offer and the Consent Solicitation expired at the Expiration Time and no tenders of Notes submitted after the Expiration Time are valid. The Tender Offer and the Consent Solicitation were subject to the satisfaction or waiver of certain General Conditions (as defined in the Statement), all of which were satisfied or waived as of the Expiration Time
In conjunction with receiving the Requisite Consents (as defined in the Statement), MJN intends to execute a supplemental indenture with respect to the Indenture (the “Supplemental Indenture”) to effect the Proposed Amendments. The Supplemental Indenture is expected to become operative on the Settlement Date. Upon becoming operative, the Proposed Amendments will apply to all Holders of the Notes remaining outstanding after the Settlement Date, and Holders may obtain the Supplemental Indenture from Reckitt upon request.
